Compare Orchid Pharma with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA AUROBINDO PHARMA ORCHID PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x -17.0 7.5 - View Chart
P/BV x 2.5 1.8 138.2% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ORCHID PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
AUROBINDO PHARMA
Mar-21
ORCHID PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs2,4651,023 240.9%   
Low Rs18333 5.4%   
Sales per share (Unadj.) Rs110.3422.8 26.1%  
Earnings per share (Unadj.) Rs-28.592.0 -31.0%  
Cash flow per share (Unadj.) Rs-1.9110.0 -1.7%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs159.9374.3 42.7%  
Shares outstanding (eoy) m40.82585.94 7.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.31.6 702.0%   
Avg P/E ratio x-43.57.4 -589.7%  
P/CF ratio (eoy) x-665.66.2 -10,794.2%  
Price / Book Value ratio x7.81.8 428.3%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m50,677397,398 12.8%   
No. of employees `000NANA-   
Total wages/salary Rs m67135,350 1.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,501247,746 1.8%  
Other income Rs m1523,809 4.0%   
Total revenues Rs m4,653251,555 1.8%   
Gross profit Rs m29481,480 0.4%  
Depreciation Rs m1,08910,554 10.3%   
Interest Rs m522745 70.1%   
Profit before tax Rs m-1,16573,990 -1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m020,098 0.0%   
Profit after tax Rs m-1,16553,892 -2.2%  
Gross profit margin %6.532.9 19.8%  
Effective tax rate %027.2 0.0%   
Net profit margin %-25.921.8 -119.0%  
BALANCE SHEET DATA
Current assets Rs m5,499198,235 2.8%   
Current liabilities Rs m1,421106,652 1.3%   
Net working cap to sales %90.637.0 245.1%  
Current ratio x3.91.9 208.2%  
Inventory Days Days2019 103.7%  
Debtors Days Days1,10152 2,132.2%  
Net fixed assets Rs m6,874135,778 5.1%   
Share capital Rs m408586 69.7%   
"Free" reserves Rs m6,121218,713 2.8%   
Net worth Rs m6,529219,299 3.0%   
Long term debt Rs m4,2751,684 253.9%   
Total assets Rs m12,373334,013 3.7%  
Interest coverage x-1.2100.3 -1.2%   
Debt to equity ratio x0.70 8,526.6%  
Sales to assets ratio x0.40.7 49.0%   
Return on assets %-5.216.4 -31.8%  
Return on equity %-17.824.6 -72.6%  
Return on capital %-6.033.8 -17.6%  
Exports to sales %88.153.8 163.9%   
Imports to sales %37.316.4 227.3%   
Exports (fob) Rs m3,966133,248 3.0%   
Imports (cif) Rs m1,67740,615 4.1%   
Fx inflow Rs m3,966133,248 3.0%   
Fx outflow Rs m1,72944,946 3.8%   
Net fx Rs m2,23788,302 2.5%   
CASH FLOW
From Operations Rs m23633,289 0.7%  
From Investments Rs m6725,987 11.2%  
From Financial Activity Rs m-1,650-13,648 12.1%  
Net Cashflow Rs m-74225,831 -2.9%  

Share Holding

Indian Promoters % 90.0 48.8 184.6%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 5.2 37.2 13.9%  
FIIs % 1.8 21.7 8.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.0 48.2 20.8%  
Shareholders   34,798 329,940 10.5%  
Pledged promoter(s) holding % 32.7 24.4 133.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   BAFNA PHARMA  AJANTA PHARMA  SANJIVANI PA  COLINZ LABOR  AAYUSH FOOD & HERBS   



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Dec 3, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS